Videofluoroscopic Swallowing Study (VFSS)



Status:Terminated
Conditions:Alzheimer Disease, Parkinsons Disease, Neurology, Neurology, Multiple Sclerosis
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:18 - Any
Updated:2/2/2019
Start Date:October 24, 2017
End Date:July 23, 2018

Use our guide to learn which trials are right for you!

A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study

The study procedure of simultaneous VFSS and DDS measurement will be completed in one day and
the subject will be followed within 2 business days after the study procedure to monitor for
adverse events.

DDS signals and VFSS will be recorded simultaneously (for the same bolus) using barium
contrast agent stimuli prepared in three consistencies: thin, mildly-thick and
moderately-thick. Subjects will undergo VFSS with simultaneous DDS using up to 5 boluses of
thin barium stimulus ("THIN-Ba"), and up to 4 boluses of barium thickened to mildly
("MILD-Ba") thick and up to 4 boluses of moderately ("MODERATE-Ba") thick barium
consistencies using Resource Thicken Up Clear Nestlé Health Science (TUC). 4, 3 and 3 boluses
for THIN-Ba, MILD-Ba and MOD-Ba will be analyzed using the classifier algorithms for
sensitivity/specificity results. According to the exploratory trial, VFSS data for safety or
efficiency can be missing for up to 14% boluses due to quality of VFSS recording. To
compensate for potential losses of boluses due to missing gold standard (VFSS) data, 5, 4 and
4 boluses will be collected for the three consistencies respectively . The DDS signals will
be sent to a dedicated application software installed at the CRO, which interprets the
acceleration data and displays the examination result. The VFSS recording will be sent to CRO
and provided for blinded assessment by the independent central VFSS laboratory.The study
procedure of simultaneous VFSS and DDS measurement will be completed in one day and the
subject will be followed within 2 business days after the study procedure to monitor for
adverse events.

Inclusion Criteria:

- Adult subjects (over 18 years of age)

- Hospitalized subjects or outpatients identified as at risk of oropharyngeal dysphagia
(using local practice)

- Patients belong to one of the following groups:

- Stroke patients

- Traumatic brain injury

- Parkinson Disease (PD) stage III or higher by Hoehn and Yahr scale

- Multiple Sclerosis (MS) above age 60

- Alzheimer Disease (AD) or other Dementia

- Other medically complex hospitalized subjects not covered by the exclusion criteria
and identified as at risk of dysphagia

- Subject is able to comply with VFSS protocol to diagnose dysphagia

- Subject is able to give voluntary, written informed consent to participate in the
clinical investigation and from whom consent has been obtained / or a consultee has
consented on he subjects behalf in line with nationally agreed guidelines concerning
adults unable to consent for themselves.

Exclusion Criteria:

- Presence of nasogastric / nasojejunal feeding tube at the time of VFSS test

- Currently has a tracheostomy, or has had a tracheostomy in the past year

- Had posterior cervical spine surgery and/or carotid endarterectomy in the last 6
months

- Had significant surgery to the mouth and/or neck, for example resection for oral or
pharyngeal cancer, radical neck dissection, anterior cervical spine surgery, orofacial
reconstruction, pharyngoplasty, or thyroidectomy. Routine tonsillectomy and/or
adenoidectomy are not excluded

- Experienced non-surgical trauma to the neck (e.g., knife wound) resulting in
musculoskeletal or nerve injury in the neck.

- Received radiation or chemotherapy to the oropharynx or neck for cancer.

- Allergy to oral radiographic contrast media (specifically barium)

- Distorted oropharyngeal anatomy (e.g. pharyngeal pouch)

- Cognitive impairment that prevents them from being able to comply with study
instructions and procedures

- Known to be pregnant at the time of enrollment

- Currently has significant facial hair at the location of sensor adherence and are
unwilling/unable to be shaved

- Any patients the local investigator finds that participation would not be in patients'
best interest
We found this trial at
13
sites
26W171 Roosevelt Road
Wheaton, Illinois 60187
?
mi
from
Wheaton, IL
Click here to add this to my saved trials
13001 E. 17th Pl
Aurora, Colorado 80045
303-724-5000
University of Colorado Denver The University of Colorado Denver | Anschutz Medical Campus provides a...
?
mi
from
Aurora, CO
Click here to add this to my saved trials
Boston, Massachusetts 02118
?
mi
from
Boston, MA
Click here to add this to my saved trials
355 East Erie Street
Chicago, Illinois 60611
?
mi
from
Chicago, IL
Click here to add this to my saved trials
2049 E 100th St
Cleveland, Ohio 44106
(216) 444-2200
Cleveland Clinic Foundation The Cleveland Clinic (formally known as The Cleveland Clinic Foundation) is a...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Detroit, Michigan 48202
?
mi
from
Detroit, MI
Click here to add this to my saved trials
?
mi
from
Downey, CA
Click here to add this to my saved trials
?
mi
from
Helsinki,
Click here to add this to my saved trials
740 South Limestone
Lexington, Kentucky 40536
?
mi
from
Lexington, KY
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
102 Irving Street Northwest
Washington, District of Columbia 20010
?
mi
from
Washington,
Click here to add this to my saved trials
White Plains, New York 10605
?
mi
from
White Plains, NY
Click here to add this to my saved trials